Today's news from Moderna and Merck begs the question: What is a personalized cancer vaccine?

How each outlet headlined it

• STAT

  Today's news from Moderna and Merck begs the question: What is a personalized cancer vaccine?
• Investing.com Stocks

  Analysis-Moderna, Merck breakthrough could usher in wave of cancer vaccines
• Reuters

  Moderna, Merck breakthrough could usher in wave of cancer vaccines reut.rs/4x9tv5M
• CNBC left

  An experimental personalized cancer vaccine from Merck and Moderna showed positive initial results in its first-ever late-stage trial.
• Yahoo Finance

  After Moderna stock surge of 177% on cancer drug breakthrough, here's what Wall Street thinks happens next
• The Washington Post left

  An experimental drug that uses messenger RNA to deliver a vaccine customized to a patient’s tumors effectively prevented skin cancer recurrence in a large-scale clinical trial, according to new results announced by drugmakers. https://wapo.st/4qo5t4F
• Investor's Business Daily right

  Moderna and Merck scored a big win for their cancer vaccine on Wednesday. But analysts say it's too early to call it a home run. The post Moderna's Cancer Vaccine: Are Investors Putting The Cart Before The Horse? appeared first on Investor's Business Daily.